Shannon Maude Research Program News Updates
1 - 4 of 4
T-cell Therapy Pioneered at CHOP Shows Persistent Benefits in Young Leukemia Patients
Published on
Updated results from a global clinical trial of the CAR T-cell therapy for ALL reveal that children and young adults continued to show high rates of durable, complete remission of their disease.
Pediatric Immunotherapy: What’s Next for CAR-T Therapy
Published on
The FDA approval of Kymriah™ has shifted the paradigm for pediatric cancer treatment — and at Children's Hospital of Philadelphia, more cell therapies are on the horizon.
FDA Approves Personalized Cellular Therapy for Advanced Leukemia Developed by University of Pennsylvania and Children’s Hospital of Philadelphia
Published on
This is a game changer for the treatment of pediatric patients battling leukemia and a pivotal milestone in this new era of cellular therapies that treat cancer with a patient’s own immune system.
FDA Committee Recommends Approving First Cell Therapy to Successfully Treat Cancer
Published on
The experimental, personalized cell therapy that amps up the patient's own immune system has passed a critical milestone in the path to full FDA approval.